Align Technology, Inc. is a global medical device company primarily engaged in the design, manufacture, and marketing of Invisalign clear aligners, Vivera retainers, iTero intraoral scanners, and exocad CAD/CAM software. The company's vision is to revolutionize orthodontic and restorative dentistry through digital treatment planning. Align's key objectives are to establish clear aligners as the principal solution for malocclusions, iTero scanners as the preferred scanning technology, and exocad CAD/CAM software as the dental restorative solution of choice.

• Employees: 21,610 (as of December 31, 2023)
• Geographic Footprint: More than 100 countries
• Headquarters: Tempe, Arizona
• Founded: Not explicitly stated in the 10-K
• Number of locations/facilities: 13 fabrication and treatment locations
• Revenue: $3.862 billion (FY2023)
• Key Subsidiaries/Brands: Invisalign, Vivera, iTero, exocad

• CEO: Joseph M. Hogan
• CFO: John F. Morici
• Chief Legal and Regulatory Officer: Julie Coletti
• Global Human Resources: Stuart Hockridge
• Global Operations: Emory M. Wright

Key executives have extensive experience in medical devices, technology, and finance.

• Annual Revenue: $3.862 billion (FY2023)
• Net Income: $445.1 million
• Total Assets: $6.084 billion
• Employees: 21,610 (as of December 31, 2023)
• Key Financial Highlights: Revenue increased by 3.4% year-over-year; Net income of $445.1 million; Operating cash flow of $785.8 million

Align Technology offers a range of products and services including:

• Invisalign Clear Aligners: Custom-made clear aligners for treating malocclusions.
• Vivera Retainers: Custom clear retainers for maintaining tooth position.
• iTero Intraoral Scanners: Digital scanning systems for restorative and orthodontic procedures.
• exocad CAD/CAM Software: Software for dental laboratories and practitioners for restorative dentistry.

Align operates through two segments:

• Clear Aligner: Represents approximately 83% of worldwide net revenues (FY2023).
• Imaging Systems and CAD/CAM Services: Represents approximately 17% of worldwide net revenues (FY2023).

Align's strategy is focused on revolutionizing dentistry through digital solutions. Key strategic initiatives include:

• International expansion.
• GP dentist treatment.
• Patient demand creation.
• Orthodontist utilization.
• Innovation in products and services.
• Investment in manufacturing and supply chain.

Align operates in the medical device industry, specifically within the dental and orthodontic markets. Key trends include:

• Increasing adoption of digital dentistry.
• Growing demand for clear aligner therapy.
• Technological advancements in intraoral scanning and CAD/CAM software.
• Competition from traditional orthodontic treatments and other clear aligner manufacturers.

• Macroeconomic and External Risks: Global and regional economic conditions, inflation, currency fluctuations, and military conflicts.
• Business and Industry Risks: Competition, changing customer preferences, and dependence on key products.
• Operational Risks: Supply chain disruptions, manufacturing inefficiencies, and IT system failures.
• Legal, Regulatory and Compliance Risks: Antitrust and competition regulations, product regulations, and data privacy laws.